You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Aspen Global Inc Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ASPEN GLOBAL INC, and what generic and branded alternatives to ASPEN GLOBAL INC drugs are available?

ASPEN GLOBAL INC has seven approved drugs.

Summary for Aspen Global Inc

US Patents:	0
Tradenames:	8
Ingredients:	6
NDAs:	7
Drug Master File Entries:	1

Drugs and US Patents for Aspen Global Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Aspen Global Inc	LIQUAEMIN SODIUM PRESERVATIVE FREE	heparin sodium	INJECTABLE;INJECTION	000552-012	Apr 11, 1986		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Aspen Global Inc	LIQUAEMIN SODIUM PRESERVATIVE FREE	heparin sodium	INJECTABLE;INJECTION	000552-011	Apr 11, 1986		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Aspen Global Inc	HEPARIN SODIUM	heparin sodium	INJECTABLE;INJECTION	000552-010	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Aspen Global Inc	HEXADROL	dexamethasone	TABLET;ORAL	012675-009	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Aspen Global Inc	LIQUAEMIN SODIUM	heparin sodium	INJECTABLE;INJECTION	000552-002	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Aspen Global Inc	HYDROXYPROGESTERONE CAPROATE	hydroxyprogesterone caproate	SOLUTION;INTRAMUSCULAR	200271-001	Aug 24, 2015		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Aspen Global Inc	HEXADROL	dexamethasone sodium phosphate	INJECTABLE;INJECTION	014694-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Aspen Global Inc

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Aspen Global Inc	ORGARAN	danaparoid sodium	INJECTABLE;INJECTION	020430-001	Dec 24, 1996	5,164,377	⤷ Subscribe
Aspen Global Inc	CYCLESSA	desogestrel; ethinyl estradiol	TABLET;ORAL-28	021090-001	Dec 20, 2000	4,628,051	⤷ Subscribe
Aspen Global Inc	CYCLESSA	desogestrel; ethinyl estradiol	TABLET;ORAL-28	021090-001	Dec 20, 2000	4,616,006	⤷ Subscribe
Aspen Global Inc	CYCLESSA	desogestrel; ethinyl estradiol	TABLET;ORAL-28	021090-001	Dec 20, 2000	4,544,554	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.